Abstract
Microbial exposure at barrier interfaces drives development and balance of the immune system, but the consequences of local infections for systemic immunity and secondary inflammation are unclear. Here, we show that skin exposure to the bacterium Staphylococcus aureus persistently shapes the immune system of mice with specific impact on progenitor and mature bone marrow neutrophil and eosinophil populations. The infection-imposed changes in eosinophils were long-lasting and associated with functional as well as imprinted epigenetic and metabolic changes. Bacterial exposure enhanced cutaneous allergic sensitization and resulted in exacerbated allergen-induced lung inflammation. Functional bone marrow eosinophil reprogramming and pulmonary allergen responses were driven by the alarmin interleukin-33 and the complement cleavage fragment C5a. Our study highlights the systemic impact of skin inflammation and reveals mechanisms of eosinophil innate immune memory and organ cross-talk that modulate systemic responses to allergens.
| Originalsprache | Englisch |
|---|---|
| Aufsatznummer | eadp6231 |
| Zeitschrift | Science Immunology |
| Jahrgang | 10 |
| Ausgabenummer | 106 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 04.2025 |
Fördermittel
We are thankful to E. Jacobsen for provision of EoCre mice. We acknowledge the services and support of CeMM BSF and Molecular Discovery Platform-Metabolomics. We thank U. Kaindl (Center for Anatomy and Cell Biology, Medical University of Vienna, Austria) for technical support. We thank all members of the Research Division Infection Biology for discussion and critical feedback throughout the duration of this project. This study was funded by the Austrian Science Fund (FWF; P31113-B30 and P36502-B) to P.S. and SFB-F061(P04) and to S.K. This research was funded in whole, or in part, by the Austrian Science Fund (FWF) (P36502 and P31113), a cOAlition S organization. For the purpose of open access, the authors will make the author accepted manuscript version available under a CC BY public copyright license. Acknowledgments: We are thankful to e. Jacobsen for provision of EoCre mice. We acknowledge the services and support of cemm BSF and molecular Discovery Platform– metabolomics. We thank u. Kaindl (center for Anatomy and cell Biology, medical university of Vienna, Austria) for technical support. We thank all members of the Research Division infection Biology for discussion and critical feedback throughout the duration of this project. Funding: this study was funded by the Austrian Science Fund (FWF; P31113-B30 and P36502-B) to P.S. and SFB-F061(P04) and to S.K. this research was funded in whole, or in part, by the Austrian Science Fund (FWF) (P36502 and P31113), a coAlition S organization. For the purpose of open access, the authors will make the author accepted manuscript version available under a cc By public copyright license. Author contributions: conceptualization: m.R. and P.S. investigation (experimental): m.R., A. Farhat, S.Z., l.P., A. Fokina, A. hladik, K.l., J.B., A.Z., m.i., t.K., m.e., and A.S. investigation (bioinformatics): A. hakobyan, J.m., n.n., n.F., V.D., and m.R. Funding acquisition: P.S. and S.K. Resources: S.K., P.S., J. Köhl, o.u., J. Kovarik, K.h., and A.V. Supervision: P.S. Writing— original draft: m.R. and P.S. Writing—review and editing: All authors. Competing interests: K.h. and A.V. are cofounders and shareholders of Aptarion Biotech and hold background iP on Aon-D21. K.h. and A.V. are also inventors on a background patent and divisional uS patents and patent applications around the c5a inhibitor Aon-D21. the other authors declare that they have no competing interests. Data and materials availability: the scRnA-seq, bulk RnA-seq, and AtAc-seq data have been deposited in geo under the following accession numbers: scRnA-seq (gSe287038), bulk RnA-seq (gSe286908), AtAc-seq (gSe287520). All original codes have been deposited at Zenodo and are accessible via the following links: scRnA-seq (https:// doi.org/10.5281/zenodo.14865685), bulk RnA-seq (https://doi.org/10.5281/zenodo.14697669), and AtAc-seq (https://doi.org/10.5281/zenodo.14699506). the metabolomics data are accessible at Zenodo via https://doi.org/10.5281/zenodo.14623014. tabulated data underlying the figures are provided in data file S8. All other data needed to evaluate the conclusions in the paper are present in the paper or the Supplementary materials.
| Träger | Trägernummer |
|---|---|
| Molecular Discovery Platform-Metabolomics | |
| CeMM BSF | |
| Medizinische Universität Wien | |
| Austrian Science Fund | SFB-F061, P04, P31113-B30, P36502-B, P31113, P36502 |
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
Strategische Forschungsbereiche und Zentren
- Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)
DFG-Fachsystematik
- 2.21-05 Immunologie
- 2.21-03 Medizinische Mikrobiologie und Mykologie, Hygiene, Molekulare Infektionsbiologie
- 2.22-22 Klinische Immunologie und Allergologie
- 2.22-13 Pneumologie, Thoraxchirurgie
Fingerprint
Untersuchen Sie die Forschungsthemen von „Eosinophil innate immune memory after bacterial skin infection promotes allergic lung inflammation“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver